Single loading infusion
The default for most healthy adults optimizing recovery, inflammation, and baseline vitality.
- One infusion, monitored
- Reassess at 6 months
- Maintenance if clear response
Most patients start with a single infusion, and the 6-month review decides what happens next. IV mesenchymal stem cell (MSC) therapy isn't a monthly infusion, and the physician team sets any interval at each review.
Medically reviewed by the physician team at Hospital Angeles ยท October 2026
MSCs aren't like vitamins. Infusion frequency is governed by biology, not convenience.
The paracrine effects of a single well-dosed infusion unfold over several months. Infusing monthly layers doses inside a window that's still processing the previous infusion. Layering more inside that window doesn't multiply benefit, it pushes past a meaningful ceiling.
A single systemic MSC infusion delivers enough cells for meaningful biodistribution and signaling. The response peaks around 12 to 16 weeks and holds.
A clinic recommending very frequent MSC infusions should be able to clearly explain the medical reasoning, dosing strategy, and expected biological rationale behind that recommendation. In many cases, monthly infusions may reflect unnecessarily low dosing or an overly aggressive maintenance model.
See the recovery timeline, week by weekMost patients start with a single session. A subset benefit from two to three, decided at review.
The default for most healthy adults optimizing recovery, inflammation, and baseline vitality.
Patients with higher systemic inflammatory burden or specific autoimmune-adjacent profiles may benefit from a repeat at six months.
Reserved for high-burden cases under physician direction. Not a standing default: the indication has to be there.
Once the loading response is established, the 6-month review decides what happens next. A maintenance infusion, when there is one, comes as the response fades, not on a calendar. Patients with high systemic inflammatory burden may come back sooner; others stretch longer as their signal holds.
We make this decision at each review based on how the response is actually holding, not on a pre-set subscription model.
Read how long it lastsMonth 0
Intake, infusion, follow-up calls at 1 week, then at 1, 3 and 6 months, then once a year.
Month 6
A look at how you're doing, alongside anything your own labs show. The 6-month review decides what happens next: a second loading dose, maintenance, or holding.
Month 12
From here, follow-up calls are once a year. Any further infusion is scheduled against response rather than the calendar.
Year 2+
Frequency adjusted to what the response actually requires, decided at review.
Yes. Almost every joint and spine patient also receives a systemic IV the same day. The injection comes first, 15 to 30 minutes, then the infusion, about 45 minutes.
Joint therapy add-onThe physician team won't recommend something you don't need. If the biologic case isn't there, they'll tell you. If there's a clinical reason to tighten cadence, that reason is made explicit in the plan.
Your loading plan and maintenance rhythm come out of the physician team's review, not the website. The physician team sets cadence against your baseline, not a subscription calendar.
Not medical advice. Individual results vary. Cadence is physician-determined against baseline and goals.